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Abstract
Fetal alcohol spectrum disorders (FASD) are a consequence of prenatal alcohol expo-
sure (PAE). The etiology of the complex FASD phenotype with growth deficit, birth
defects, and neurodevelopmental impairments is under extensive research. Both
genetic and environmental factors contribute to the wide phenotype: chromosomal
rearrangements, risk and protective alleles, environmental-induced epigenetic alter-
ations as well as gene-environment interactions are all involved. Understanding the
molecular mechanisms of PAE can provide tools for prevention or intervention of the
alcohol-induced developmental disorders in the future. By revealing the alcohol-
induced genetic and epigenetic alterations which associate with the variable FASD
phenotypes, it is possible to identify biomarkers for the disorder. This would enable
early diagnoses and personalized support for development of the affected child.
1 | INTRODUCTION
Prenatal alcohol exposure (PAE) is a leading cause of preventable
mental disability and birth defects in the Western world. PAE can pro-
duce fetal alcohol spectrum disorders (FASD), which is an umbrella
term for all alcohol-related neurodevelopmental disorders and birth
defects. This continuum of disabilities consists of growth deficits,
physical abnormalities, neurocognitive and behavioral deficits, and
increased vulnerability to mental health problems and other com-
orbidities.1-3 There are four diagnostics categories within FASD. The
most severe category is fetal alcohol syndrome (FAS) with diagnosed
pre- and post-natal growth retardation—especially in the head—as
well as characteristic facial dysmorphology, and central nervous sys-
tem alterations. In addition to FAS, there is partial fetal alcohol syn-
drome, alcohol-related neuronal disorders, and alcohol-related birth
defects.4 There are several factors contributing to the complex pheno-
type of the alcohol-induced disorders, such as genetic susceptibility,
drinking pattern, timing of drinking, amount of alcohol as well as
maternal metabolism and tolerance for alcohol5-8 (Figure 1). The esti-
mated prevalence of FASD ranges from 3% to 5% in Europe and
North America to over 10% in South Africa,9 but owing to the
complex, highly variable phenotype, and lack of proper diagnostic
tools, FASD is severely underdiagnosed. In a recent study among first-
graders in the United States, 222 children were diagnosed with FASD
and only two of them had previous diagnosis.10
Currently, the assignment of an FASD diagnosis is a demanding
medical diagnostic process and requires a multidisciplinary team of
experts in pediatrician, clinical genetics, clinical dysmorphology and
neuropsychology with complementary experience, qualifications, and
skills.4 Owing to the challenges in current diagnostics, a solid diagnos-
tic method is needed to separate the categories from each other as
well as to understand the wide variety of subphenotypes. Also, the
severity of defects in each category should be determined: it is
already known that FASD individuals without the full criteria of FAS
can be severely impaired in brain function.11 Furthermore, a method
to discern similar phenotypes like attention deficit hyperactivity disor-
der and autistic spectrum disorders from FASD is needed.
The complexity and broadness of the PAE-induced phenotypes
can be perceived by analyzing comorbidities in individuals with FASD
diagnosis. They are at risk of multiple comorbidities, like conduct dis-
order, receptive and expressive language disorders, and abnormal
results of function studies of peripheral nervous system, and special
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senses.3 For example, the pooled prevalence of hearing loss (for both
conductive and sensorineural), psychological disorders, and chronic
serous otitis media are 126, 97, and 77 times higher, respectively,
among individuals with FAS compared to general population.
According to a recent study, 428 comorbid conditions are co-
occurring in individuals with FASD, spanning across 18 of 22 chapters
of the International Classification of Diseases (ICD-10).3
2 | THE GENETIC BACKGROUND OF FASD
Alcohol is a teratogen that rearranges chromosomes and kills cells.
The toxic effect of alcohol is partly caused by its oxidation product
acetaldehyde, which is highly reactive toward DNA, consequently
damaging chromosomes and mutating stem cells.12,13 Owing to this, it
is not surprising that in recent studies 9% to 14% of children diag-
nosed with FASD had chromosomal deletions or duplications that
could explain at least part of the features.14-16 In addition to chromo-
somal rearrangements, twin studies have suggested that genetic
factors—susceptibility or resistance alleles—could affect the alcohol-
induced phenotype. Monozygotic twins with identical genomes have
been observed to be 100% concordant for diagnosis, while dizygotic
twins who share only 50% of their DNA, were only 64% concor-
dant.17 Also, a recent research where both twins and siblings were
studied supported that conclusion: The prevalence of pairwise discor-
dance in FASD diagnosis increased from 0% in monozygotic twin pairs
to 44% in dizygotic twin pairs and continued to 59% in full-sibling
pairs and 78% in half-sibling pairs.18 It is known that the genetic relat-
edness between these four groups decreases from 100% to 50% to
50% to 25%, respectively, and this strongly supports the role of a
genetic component in the etiology of alcohol-induced developmental
disorders. However, it is essential to separate chromosomal
rearrangements from risk or protective alleles: Instead of suggested
risk alleles, an 18q12.3-q21.1 microdeletion was detected in an
affected twin in a prenatally alcohol-exposed dizygotic twin pair with
discordant FAS phenotype.19 This microdeletion resides in a known
18q deletion syndrome region, which has been associated with
growth restriction, developmental delay or intellectual deficiency, and
abnormal facial features in previous studies,20-22 and thus it likely
explains the phenotypic discordancy between the twins.
The most interesting candidate genes in the etiology of FASD are
involved in alcohol metabolism: alcohol dehydrogenase (ADH) con-
verts alcohol to acetaldehyde and aldehyde dehydrogenase subse-
quently converts acetaldehyde to less harmful acetate. The human
What's already known about this topic?
• Several factors contribute to the complex phenotype of
fetal alcohol spectrum disorders
What does this study add?
• Current knowledge about genetics and epigenetics in the
etiology of FASD
• A potential method for early diagnosis or even preven-
tion of FASD
F IGURE 1 Several genetic and
environmental factors during
developmental periods are
contributing to the complex FASD
phenotype
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FASD studies have focused on three ADH loci and their alleles.
According to these previous studies, maternal alleles that are associated
with efficient metabolism of alcohol are underrepresented in FASD
individuals.23-25 However, the association between ADH alleles and
FASD seems to be more complex: Some of the ADH alleles have been
associated to alcohol addiction in previous studies,26 which means that
mothers with a certain genotype could consume more alcohol.
3 | EPIGENETIC EFFECTS OF PRENATAL
ALCOHOL EXPOSURE
There is an increasing amount of evidence supporting that PAE could
affect the regulation of gene expression without DNA base pair
changes. Effects of PAE have been detected in epigenome, which is a
regulator of the genome and is needed for the normal development of
a multicellular organism. Epigenetic marks include DNA methylation
and histone modifications, which regulate gene expression prior to
transcription through their effects on chromatin structure. Also, non-
coding RNAs, such as microRNAs that inhibit the translation of mes-
senger RNAs into proteins, are a part of the epigenetic regulation.
Epigenetic variation induced in utero is a strong candidate mediator of
environmental effects and indeed, increasing amount of associations
between adverse gestational exposures and permanent changes in
offspring's DNA methylation profiles have been observed.27
3.1 | A candidate gene study: PAE-associated
alterations in IGF2/H19 locus
Several cell, animal, and human studies have revealed associations
between PAE and alterations in DNA methylation, histone modifica-
tions, and microRNAs.28 Many studies have focused on specific loci in
the genome, often on Insulin-like growth factor 2 (IGF2)/H19, which is
known to be crucial for embryonic and placental growth. This locus is
imprinted and the genes are expressed through epigenetic mecha-
nisms in parent-of-origin manner: IGF2, a major driver of growth, is
expressed from the paternal allele29 and noncoding, negative growth
controller H19 from the maternal allele.30 The locus is regulated by
allele-specific DNA methylation at the H19 imprinting control region
(H19 ICR), which contains seven binding sites for methylation-sensitive
zinc-finger proteins, CCCTC-binding factors (CTCFs). These binding
factors organize chromatin contacts and have a critical role in the
establishment and maintenance of imprinting.31
Both decreased and increased DNA methylation levels at the H19
ICR have been associated with PAE in previous mouse and human
studies.32-34 We recently introduced a genetic factor, which associated
with genotype-specific effects of PAE on placental DNA methylation,
gene expression, and phenotype of alcohol-exposed newborns.35
A polymorphism rs10732516 at the H19 ICR, in the binding site of the
CTCF regulatory protein, associates with genotype-specific changes in
DNA methylation in a parental-origin manner. Interestingly, we
observed similar genotype-specific decreased methylation levels in
in vitro fertilized placentas,36 suggesting genotype-specific sensitivity
for environmental effects in this locus.
Functional studies will reveal potential genotype-specific-
environmental-induced alterations in the binding of CTCF protein, but
the genotype-specific phenomenon itself is not novel: It is already
known that individual genotypes at specific methylation quantitative
trait loci can result in different DNA methylation patterns across
extended genomic regions.37 The underlying mechanism can be asso-
ciated directly with genetic polymorphism or with a genotype-
environment interaction. Gene-environment interaction should be
considered in methylation studies: A strong environmental factor,
such as smoking, can have effects on DNA methylation alone, but the
genotypic effects in addition to the exposure can provide more infor-
mation of the variation in DNA methylation profiles.38
3.2 | Genome-wide DNA methylation analyses
Epigenome-wide association studies (EWAS) have provided a more
inclusive comprehension of PAE-induced alterations in the methylome,
and long-lasting changes, both decreased and increased methylation
levels, have been observed in mouse studies.33,39 Only a few EWAS for
human cohorts have been performed so far and although the altered
DNA methylation levels associate with several genes presumably
involved in FASD—such as imprinted and neurodevelopmental genes—
the results are inconsistent. A meta-analysis of six cohorts (1147
exposed and 1928 unexposed newborns) did not reveal significant
effects of light-to-moderate maternal alcohol consumption on DNA
methylation in cord blood.40 A signature of 658 FASD-associated dif-
ferentially methylated CpG sites in buccal epithelial cells have been
found in a study with 110 FASD and 96 control children34 but only
161 CpG sites of these 658 were replicated in a study of 24 FASD and
24 control children's buccal cell samples.41 Also, associations between
FASD—even between one of the subphenotypes—and altered DNA
methylation levels in blood samples have been discovered in a study
with 39 children with FASD diagnosis and 64 controls, as well as in a
replication study with 7 FASD and 28 control children.42 However, the
observed methylation changes were mainly inconsistent with the previ-
ous studies and any solid biomarkers for FASD have not yet been
revealed.
The inconsistency of the EWAS studies could be explained by
several limitations: only low-to-moderate alcohol exposure, cellular
heterogeneity, different age of the affected individuals, variability in
timing and amount of exposures, limitations of the methods, or differ-
ences in genetic background, socioeconomic status and culture.
A strong environmental factor, such as maternal smoking, can be a
confounding factor in the analysis. Often women who drink also
smoke, and the separate effects of these two harmful factors or their
interactions are still unclear. Interestingly, prenatal exposure to mater-
nal smoking is associated with a larger magnitude of alterations com-
pared to PAE and with systematically replicated changes in DNA
methylation, including xenobiotic-related pathways,43-45 unlike in the
PAE EWAS studies. Furthermore, all the previous EWAS studies for
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PAE have been performed by microarrays, in which 450 000 selected
CpG sites for DNA methylation groups were analyzed (450 K microar-
ray Illumina). This is only approximately 1.6% of all the CpG sites in
the human genome and thus majority of the methylation information
is missing from the results.
3.3 | Epigenetic effects of early prenatal alcohol
exposure
Recent studies have shown that the beginning of pregnancy appears
to be particularly vulnerable to the effects of environmental factors
and disruption of these processes can have long-term effects on
development.46-48 This is a dynamic period of cell divisions, DNA rep-
lication, and epigenetic reprogramming.49 The reprogramming is fun-
damental for normal development: It removes epigenetic marks and
returns totipotency for the first cells of the new individual. In the end
of this early programming the cell-specific epigenetic profiles for ade-
quate gene function will be formed again. We have shown for the first
time that alcohol could affect adult phenotype by altering the
epigenotype of the early mouse embryo. Early PAE is capable of
changing the DNA methylation level at the epigenetically sensitive
Agouti viable yellow (Avy) allele and consequently the coat color of
alcohol-exposed offspring.50 Avy is a dominant mutation of the Agouti
locus in mouse, caused by the insertion of a retrotransposon.
Retrotransposons are transposable elements, “jumping genes,” which
by affecting gene regulation can contribute to development and dis-
ease.51,52 Interestingly, the offspring phenotype in this mouse model
was reminiscent of human FASD with craniofacial dysmorphology,
postnatal growth restriction,50 and structural53 as well as functional54
changes in central nervous system.
Instead of killing the cells, maternal alcohol consumption could
alter the establishment of epigenetic marks in the epigenetic program-
ming period of early embryo, change the gene regulation and conse-
quently bring forth the wide FASD phenotype. Several stem cell and
mouse embryo studies have revealed associations between early alco-
hol exposure and alterations in DNA methylation39,55,56 and histone
modifications.57 Although causal molecular mechanisms of early
alcohol-induced epigenetic alterations and adult phenotype have not
yet been revealed, this will be possible due to the development of
cost-effective sequencing methods. Instead of small fraction of
selected CpG sites on arrays, they will enable comprehensive and sys-
tematic examination of the whole epigenome including repetitive ele-
ments. Owing to the significant role of TEs in normal development as
well as disorders, also their potential role in alcohol-induced develop-
mental disorders should be explored in future studies.
Although early PAE-induced molecular changes can be relatively
subtle and will not terminate the development, they can be significant
for the development of brain. If they occur very early in the develop-
ment prior to the differentiation of the three germ layers, they would
be expected to be present in all tissue types. In our previous mouse
study, early PAE was associated with similar changes in gene expres-
sion in ectodermal hippocampus and main olfactory epithelium as well
as mesodermal bone marrow of infant mice, which supports our
hypothesis of early epigenetic origin of alcohol-induced disorders.53
The changes in gene regulation may have already taken place in
embryonic stem cells—in hematopoietic stem cells as well as in stem
cells of central and peripheral nervous system. These changes can be
replicated to daughter cells along cell divisions, and can be seen in the
different tissue types of an adult organism. This could prove signifi-
cant for the challenging work of diagnosing alcohol-related damage.
4 | MOLECULAR MECHANISMS OF
PAE-INDUCED EPIGENETIC ALTERATIONS
4.1 | Alcohol's effects on metionine cycle
Although the significance of prenatal environment in adult phenotype
seems to be indisputable, the molecular mechanisms underlying these
associations or causality of the observed alterations are poorly under-
stood. Alcohol consumption causes oxidative stress, which in addition to
chromosomal abnormalities also provoke enzymatic malfunction. The
reduced activity of DNA methyltransferase 1, the enzyme which is essen-
tial for maintaining of DNA methylation profiles, has been associated
with decreased global methylation level in embryos exposed to alco-
hol.58 Furthermore, it has been observed that alcohol exposure in liver
inhibits the enzymatic activity in methionine cycle.59 This one-carbon
pathway, which is found in all tissues, links folate, methyl group trans-
fers and homocysteine metabolism, and is essential for global DNA and
histone methylation levels (Figure 2). Methionine adenosyltransferase
enzyme converts methionine to S-adenosylmethionine, which is a
methyl donor substrate for methyltransferase-catalyzed reactions. In
addition to methyl groups, also S-adenosylhomocysteine is formed,
which is hydrolyzed to homocysteine. Homocysteine is remethylated
back to methionine by methionine synthase enzyme (MS) using dietary
folate or by betaine-homocysteine methyltransferase reaction using
choline's precursor betaine.60 Vitamins B6 and B12 are important cofac-
tors in the cycle: B12 in the remethylation of homocysteine to methio-
nine and B6 in the removal of homocysteine by transsulfuration
pathway.
Alcohol consumption decreases the amount of folate
(B9 vitamin)61-63 and according to a recent study, folic acid transport
F IGURE 2 The methionine cycle [Colour figure can be viewed at
wileyonlinelibrary.com]
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to the human fetus is decreased in pregnancies with chronic alcohol
exposure.64 Also, the absorption of B6 and B12 vitamins has been
associated with chronic alcohol consumption, but the results have not
always been consistent.65 Together the previous studies support the
hypothesis that alcohol exposure could affect the methionine cycle
and consequently methylation level of the epigenome in the cells of a
developing embryo.
Interestingly, based on animal studies, PAE-induced epigenetic
changes and adverse effects on the phenotype could be returned by
methyl donors.66-69 Despite of a small sample size—35 alcohol-
exposed and 35 alcohol- and choline-exposed newborns—the results
of a preliminary human clinical trial about maternal choline supple-
mentation from mid-pregnancy are encouraging: Considerable catch-
up growth in weight and head circumference as well as better visual
recognition memory were detected in infants born to choline-treated
alcoholic mothers compared to a placebo group.70 However, owing to
the unknown molecular mechanisms of choline supplements, it is not
clear whether the supplementation specifically targets alcohol-related
impairment or improves development in all infants.
4.2 | Alcohol's effect on histone acetylation
Alcohol metabolism in the liver is a source of acetate in the body.71
Interestingly, a recent mouse study reported a direct link between
alcohol consumption and changes in histone acetylation in the brain
(Figure 3).72 Acetyl groups from alcohol were rapidly incorporated into
histone acetylation in the hippocampus and prefrontal cortex by
acetyl-CoA synthase 2 (ACSS2) dependent way, which consequently
altered transcription of the genes. Behavioral tests also suggested that
this activation of memory- and learning-related genes associates with
an addictive phenotype. The observed alcohol-related associative
learning was abolished in ACSS2-knockout mice, demonstrating that
ACSS2 is required for the phenotype. In addition to the adult mice,
these dynamic histone acetylation changes were detected also in fetal
brain affected by maternal alcohol consumption.72 The effects of
alcohol-induced histone acetylation on brain development and the
role of acetylation in the molecular mechanisms of FASD should be
explored in future studies.
5 | BIOMARKERS FOR FASD
Owing to the challenges in diagnostics of FASD, particularly with the
subphenotypes in the spectrum, there is an urgent need for solid bio-
markers. At the moment early intervention is crucial for a positive out-
come in the affected child. By revealing the molecular alterations and
their associations with the phenotypes, it is possible to elucidate early
biomarkers for FASD. Early, widespread PAE-induced epigenetic alter-
ations could enable FASD diagnosis from a blood sample or simply
buccal cells from the inside of a newborn's cheek. It has been shown
by blood42 and buccal cell samples,34,41 that children with FASD could
have unique DNA methylation defects. Both buccal cells from mouth
epithelium and brain tissue are of ectodermal origin and therefore, in
theory, early epigenetic alterations in brain development could also be
seen in the buccal cells. Those changes might be used as biomarkers
for alcohol-induced neuronal disorders in the future. This hypothesis
is supported by a recent rat study, where correlation in alcohol-
associated DNA methylation alterations between peripheral tissue and
hypothalamus was observed.73 However, despite of the recently
observed high correlation for DNA methylation of CpG sites in human
buccal and brain tissue across 21 individuals (r = 0.85, P < 2.2 × 10−16),
for site-specific DNA methylation within one individual it has been
reported rather low: only 17.4% of all CpG sites were correlated at a
nominal level of significance (P < .05).74
6 | FUTURE STUDIES
Although FASD research has been mainly focused on the gestational
period and maternal environmental factors during the pregnancy, also
the impact of preconceptional—specifically paternal environment
before fertilization—has been recognized. Paternal alcohol consump-
tion can decrease the methylation level in human sperm75 and pater-
nal alcohol exposure has been associated with offspring's restricted
growth, congenital anomalies and cognitive impairment in animal
studies.76-79 The mechanism how paternal environmental exposures
can affect the offspring's development is not yet known, but it seems
that micro RNAs could explain how the alcohol-induced effects can
be transferred to the next generation.80,81
By revealing the solid molecular biomarkers for FASD, it is also
possible to understand both mitotic and meiotic epigenetic inheritance
of PAE. Owing to the several confounding factors like genetic hetero-
geneity and diverse environmental exposures, transgenerational inheri-
tance of environmental-induced epigenetic alterations are challenging
to explore in human. Also, the length of human generation hampers the
studies: Maternal transmission of transgenerational epigenetic alter-
ation needs to be observed at least in three affected generations due
to the primordial germ cells inside the both, mother and fetus—
otherwise changes could be caused by direct environmental effects.
Interestingly, there are already some rat and mouse studies, which sup-
port the transgenerational inheritance of alcohol-induced epigenetic
alterations.82,83 In the future, solid biomarkers could enable to track
inherited PAE-induced alterations also in human.
F IGURE 3 Alcohol is metabolized into acetate in the liver, which
increases the acetate level in blood. The acetate is activated by
acetyl-coA synthetase 2 (ACSS2) in both adult and fetal mouse brain.
Histone acetyltransferases use the activated acetate to acetylate
histone proteins. Histone acetylation alters the expression of learning-
and memory-related genes and facilitates alcohol-related associative
learning in adult mice72 [Colour figure can be viewed at
wileyonlinelibrary.com]
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Despite the dispersed information gathered so far, any clear cau-
sality between a molecular mechanism of PAE and its consequences
on offspring's phenotype has not been identified. In attempts to
understand the mechanisms and causality, it will be pivotal to clarify
the role of genetic (eg, chromosomal rearrangements, risk alleles) and
environmental factors (eg, alcohol and smoking exposure, nutrition) in
the FASD phenotype, and to explore their interactions. Furthermore,
the effects of alcohol on different developmental periods should be
examined. This all is possible by systematic research with modern
methods and adequate models. Also, invaluable human cohorts with
biological samples and developmental information will be needed. In
future studies, by understanding the mechanism and consequences of
molecular alterations caused by PAE, it is possible to clarify the phe-
notypic categories and also their relation to comorbidities. This would
also provide tools for diagnosis and prognostic markers, and even
establish methods to prevent or intervene in the alcohol-induced
developmental disorders.
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